5,7-Dichloroimidazo[1,2-a]pyrimidine hydrochloride

Catalog No.: 
ACYNQN436
CAS No.: 
1858249-97-4
Molecular Formula: 
C6H4Cl3N3
Molecular Weight: 
224.48
5,7-Dichloroimidazo[1,2-a]pyrimidine hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg90%$478.00InquiryInquiry
1g90%$1185.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5,7-Dichloroimidazo[1,2-a]pyrimidine hydrochloride
IUPAC Name5,7-dichloroimidazo[1,2-a]pyrimidine hydrochloride
MDL No.MFCD27922575
Molecular FormulaC6H4Cl3N3
Molecular Weight224.48
SMILESClC1=NC2=NC=CN2C(Cl)=C1.[H]Cl
InChI KeyRJFZWXDKYCMIDR-UHFFFAOYSA-N
Synonym5,7-DICHLORO-IMIDAZO[1,2-A]PYRIMIDINE HCL;5,7-Dichloroimidazo[1,2-a]pyrimidine hydrochloride
CAS No.1858249-97-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACYNQN436 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKXJG657 route compound structure diagram
    ACKXJG6573764-01-0In Stock
  2. Plus
  3. ACDLYM406 route compound structure diagram
    ACDLYM4065587-42-8In Stock
  4. Then
  5. ACYNQN436 route product structure diagram
    ACYNQN4361858249-97-4
Inquiry

2. ACYNQN436 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTRMX927 route compound structure diagram
    ACTRMX927555-75-9
  2. Plus
  3. ACKXJG657 route compound structure diagram
    ACKXJG6573764-01-0In Stock
  4. Then
  5. ACYNQN436 route product structure diagram
    ACYNQN4361858249-97-4
Inquiry

3. ACYNQN436 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACYNQN436 route product structure diagram
    ACYNQN4361858249-97-4
Inquiry

Comments (0)